IDEXX Laboratories Inc (IDXX)
Gross profit margin
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gross profit (ttm) | US$ in thousands | 2,380,648 | 2,336,155 | 2,288,099 | 2,240,069 | 2,189,970 | 2,148,730 | 2,107,374 | 2,048,556 | 2,004,338 | 1,975,832 | 1,942,127 | 1,917,403 | 1,889,432 | 1,842,513 | 1,792,198 | 1,682,232 | 1,571,040 | 1,492,687 | 1,415,031 | 1,393,542 |
Revenue (ttm) | US$ in thousands | 3,897,506 | 3,844,819 | 3,784,803 | 3,724,853 | 3,660,953 | 3,587,920 | 3,514,054 | 3,430,970 | 3,367,324 | 3,339,846 | 3,308,606 | 3,274,202 | 3,215,360 | 3,135,208 | 3,046,576 | 2,858,026 | 2,706,655 | 2,591,163 | 2,474,677 | 2,457,188 |
Gross profit margin | 61.08% | 60.76% | 60.45% | 60.14% | 59.82% | 59.89% | 59.97% | 59.71% | 59.52% | 59.16% | 58.70% | 58.56% | 58.76% | 58.77% | 58.83% | 58.86% | 58.04% | 57.61% | 57.18% | 56.71% |
December 31, 2024 calculation
Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $2,380,648K ÷ $3,897,506K
= 61.08%
The gross profit margin of IDEXX Laboratories Inc has been showing a positive trend over the past few years, indicating strong performance in generating sales revenue after accounting for the cost of goods sold. The margin has steadily increased from 56.71% in March 2020 to 61.08% in December 2024. This upward trajectory reflects the company's ability to effectively manage production costs and optimize pricing strategies to enhance profitability.
The consistent improvement in gross profit margin demonstrates IDEXX Laboratories Inc's efficiency in controlling its direct costs associated with producing goods and services. This trend suggests that the company is effectively managing its manufacturing, operational, and supply chain processes to maintain a competitive advantage in its industry.
Investors and stakeholders may view the rising gross profit margin positively as it indicates the company's ability to generate higher profits from each dollar of revenue. This trend also reflects IDEXX Laboratories Inc's strength in managing its cost structure and maximizing its profitability, which could contribute to its overall financial health and sustainability in the long term.
Peer comparison
Dec 31, 2024